| Analysis at 5/5/2026 | YTD | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Performance | 5.45% | 46.35% | 47.25% | 67.73% |
| Analysis at 5/5/2026 | 1 year | 3 years | 5 years |
|---|---|---|---|
| Volatility | 18.78% | 17.86% | 16.93% |
| Negative volatility | 6.19% | 10.21% | 10.06% |
| Sharpe | 1.97 | 0.66 | 0.53 |
| Sortino | 5.97 | 1.16 | 0.89 |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
| Candriam Eq. L Biotechnology C $ | 5.46% | 4.61% | 3.44% | 9.08% | 22.51% | 5.45% | |
| Equity Sector - Biotechnology | 16.35% | 15.35% | 0.35% | 6.70% | 8.38% | -3.61% | |